Trials / Completed
CompletedNCT00663351
Safety and Effectiveness Study of the Reflection Ceramic Acetabular System
Post Approval Study: Reflection Ceramic Acetabular System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 456 (actual)
- Sponsor
- Smith & Nephew, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System.
Detailed description
This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System. Randomized Non-inflammatory Arthritis, Randomized Inflammatory and Continued Access Cohorts patients previously enrolled in the IDE study will be evaluated annually through five (5) year follow-up. In addition, all patients enrolled in the original study cohorts as well as the continued access patients will be sent a letter questionnaire annually at the 6-10 year postoperative time point to assess the patient's general well-being and if the study components are still in place
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Reflection Ceramic-Ceramic Total Hip Replacement | Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem. |
| DEVICE | Reflection FSO V Total Hip Replacement | Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem. |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2014-10-01
- Completion
- 2014-12-01
- First posted
- 2008-04-22
- Last updated
- 2022-10-13
- Results posted
- 2022-10-13
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00663351. Inclusion in this directory is not an endorsement.